HER2 Gene Protein Assay Is Useful to Determine HER2 Status of Breast Carcinoma with HER2 IHC and FISH Double Equivocal Results

被引：0
|
作者：
Li, Zaibo
Hou, Yanjun
Nitta, Hiroaki
机构：
[1] Ohio State Univ, Columbus, OH 43210 USA
[2] Ventana Med Syst Inc, Tucson, AZ USA
来源：
MODERN PATHOLOGY | 2016年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
210
引用
收藏
页码：54A / 54A
页数：1
相关论文
共 50 条
  • [21] Evaluating Low HER2 Status in Invasive Breast Carcinoma via HER2 Immunohistochemistry, with HER2 FISH Correlation: A Cohort of 112 Patients
    Ardor, Gokce Deniz
    Komforti, Miglena K.
    Hanna, Helena
    Ibanoglu, Onur
    Lochala, Abigail
    Nassar, Aziza
    BREAST JOURNAL, 2023, 2023
  • [22] HER2 Status in Breast Carcinoma by Dual ISH in HER2 Equivocal IHC Population: Comparison Between 2013 and 2018 Guidelines in Reference Center
    De La Iglesia Niveyro, Paola
    Wernicke, Alejandra
    Pandolfi, Julieta
    Pastorutti, Ana
    Garcia-Rivello, Hernan
    LABORATORY INVESTIGATION, 2019, 99
  • [23] HER2 Status in Breast Carcinoma by Dual ISH in HER2 Equivocal IHC Population: Comparison Between 2013 and 2018 Guidelines in Reference Center
    De La Iglesia Niveyro, Paola
    Wernicke, Alejandra
    Pandolfi, Julieta
    Pastorutti, Ana
    Garcia-Rivello, Hernan
    MODERN PATHOLOGY, 2019, 32
  • [24] Characteristics of HER2 FISH-Equivocal Breast Cancers and the Impacts on HER2 Status of 2018 ASCO/CAP Guideline
    Kong, Hui
    Bai, Qianming
    Lu, Hongfen
    Zhou, Xiaoyan
    Yang, Wentao
    LABORATORY INVESTIGATION, 2019, 99
  • [25] Characteristics of HER2 FISH-Equivocal Breast Cancers and the Impacts on HER2 Status of 2018 ASCO/CAP Guideline
    Kong, Hui
    Bai, Qianming
    Lu, Hongfen
    Zhou, Xiaoyan
    Yang, Wentao
    MODERN PATHOLOGY, 2019, 32
  • [26] Stratification of breast carcinomas with double-equivocal HER2 status
    Marchio, C.
    Trisolini, E.
    Maletta, F.
    Annaratone, L.
    Scalzo, M. S.
    Mascali, D.
    di Cantogno, L. Verdun
    Medico, E.
    Sapino, A.
    CANCER RESEARCH, 2016, 76
  • [27] HER2 or not HER2: That is the question
    Burstein, HJ
    Winer, EP
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 3656 - 3659
  • [28] Reassessment of HER2 status in HER2 negative or HER2 unknown breast cancer patients with recurrent metastatic disease by analyzing serum HER2 and HER2 status of circulating tumor cells.
    Fehm, T.
    Lane, N.
    Solomayer, E.
    Wallwiener, D.
    Uhr, J.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S40 - S40
  • [29] HER2 0, HER2 1+and HER2 2+/FISH Negative Breast Cancers Are Biologically Different
    Mon, Khin Su
    Zhang, Hui
    Aragao, Alessa
    Tang, Ping
    LABORATORY INVESTIGATION, 2023, 103 (03) : S182 - S183
  • [30] Reassessment of HER2 status in breast cancer patients with initially HER2 negative or HER2 unknown primary tumors at the time of metastatic disease by serum HER2 and HER2 status of circulating tumor cells
    Fehm, T.
    Solomayer, E.
    Uhr, J.
    Wallwiener, D.
    ONKOLOGIE, 2008, 31 : 51 - 51
12345